Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,670 | 8 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,240 | 1 | 23.6% |
| Honoraria | $3,500 | 1 | 9.0% |
| Food and Beverage | $3,454 | 38 | 8.8% |
| Travel and Lodging | $2,877 | 15 | 7.4% |
| Gift | $359.98 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $27,698 | 30 | $0 (2024) |
| Lundbeck LLC | $9,368 | 15 | $0 (2018) |
| ARGENX US, INC. | $696.14 | 12 | $0 (2023) |
| PFIZER INC. | $550.00 | 1 | $0 (2022) |
| NeuroMetrix Inc | $359.98 | 1 | $0 (2017) |
| HARMONY BIOSCIENCES LLC | $220.98 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $167.85 | 1 | $0 (2017) |
| Alnylam Pharmaceuticals Inc. | $40.61 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,963 | 7 | JAZZ PHARMACEUTICALS INC. ($5,915) |
| 2023 | $14,603 | 29 | Jazz Pharmaceuticals Inc. ($13,774) |
| 2022 | $8,598 | 10 | JAZZ PHARMACEUTICALS INC. ($7,968) |
| 2019 | $41.39 | 1 | JAZZ PHARMACEUTICALS INC. ($41.39) |
| 2018 | $4,747 | 7 | Lundbeck LLC ($4,747) |
| 2017 | $5,149 | 10 | Lundbeck LLC ($4,621) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| 08/21/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $122.20 | General |
| 08/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $149.79 | General |
| Category: NEUROLOGY | ||||||
| 04/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $142.08 | General |
| Category: NEUROLOGY | ||||||
| 02/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $48.10 | General |
| Category: Narcoplepsy | ||||||
| 02/08/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $140.43 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $139.85 | General |
| Category: NEUROLOGY | ||||||
| 11/16/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $40.61 | General |
| Category: Genetic Disease | ||||||
| 09/20/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $146.46 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Travel and Lodging | Cash or cash equivalent | $104.92 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,240.00 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $74.67 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $49.69 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Travel and Lodging | Cash or cash equivalent | $32.48 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROLOGY | ||||||
| 08/24/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Travel and Lodging | Cash or cash equivalent | $427.81 | General |
| Category: NEUROLOGY | ||||||
| 08/24/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Travel and Lodging | Cash or cash equivalent | $348.37 | General |
| Category: NEUROLOGY | ||||||
| 07/18/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $145.34 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 04/12/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $92.14 | General |
| Category: SLEEP MEDICINE | ||||||
| 03/03/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2023 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | In-kind items and services | $224.87 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 481 | 549 | $362,798 | $44,964 |
| 2022 | 13 | 481 | 548 | $345,647 | $45,457 |
| 2021 | 9 | 419 | 472 | $295,141 | $41,140 |
| 2020 | 9 | 445 | 508 | $282,184 | $42,925 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 142 | $97,188 | $11,510 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 75 | 103 | $59,406 | $8,383 | 14.1% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Facility | 2023 | 64 | 64 | $32,754 | $4,863 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 37 | $22,746 | $4,849 | 21.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 29 | 29 | $44,268 | $3,104 | 7.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 24 | $17,473 | $2,766 | 15.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $15,083 | $2,338 | 15.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Facility | 2023 | 55 | 55 | $16,546 | $2,158 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $14,085 | $1,278 | 9.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 11 | 11 | $18,602 | $1,225 | 6.6% |
| 95808 | Sleep study in sleep lab | Office | 2023 | 12 | 13 | $11,862 | $980.98 | 8.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $6,445 | $774.84 | 12.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 20 | 20 | $6,340 | $734.20 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 120 | $85,448 | $9,424 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 98 | $57,208 | $7,865 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 52 | $36,772 | $6,152 | 16.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $30,120 | $4,559 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 30 | $23,478 | $3,466 | 14.8% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Facility | 2022 | 38 | 38 | $15,462 | $3,059 | 19.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 17 | 17 | $21,920 | $1,893 | 8.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Facility | 2022 | 34 | 34 | $7,506 | $1,423 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $8,002 | $1,362 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $10,983 | $1,201 | 10.9% |
| 95808 | Sleep study in sleep lab | Office | 2022 | 14 | 14 | $10,703 | $1,124 | 10.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 11 | 11 | $13,558 | $1,112 | 8.2% |
About Dr. Mitchell Miglis, MD
Dr. Mitchell Miglis, MD is a Neurology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972779411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Miglis, MD has received a total of $39,101 in payments from pharmaceutical and medical device companies, with $5,963 received in 2024. These payments were reported across 64 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($19,670).
As a Medicare-enrolled provider, Miglis has provided services to 1,826 Medicare beneficiaries, totaling 2,077 services with total Medicare billing of $174,486. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine, Clinical Neurophysiology
- Location Stanford, CA
- Active Since 05/05/2008
- Last Updated 11/10/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972779411
Products in Payments
- XYWAV (Drug) $20,030
- NORTHERA (Drug) $9,368
- SUNOSI (Drug) $4,560
- VYVGART (Drug) $696.14
- Quell (Device) $359.98
- ACTIVA (Device) $167.85
- WAKIX (Drug) $140.24
- Wakix (Drug) $80.74
- XYREM (Drug) $41.39
- AMVUTTRA (Drug) $40.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Stanford
Gregory Albers, Md, MD
Neurology — Payments: $500,221
John Day, Md, MD
Neurology — Payments: $367,934
Robert Cowan, Md, MD
Neurology — Payments: $253,351
Josef Parvizi, Md, Phd, MD, PHD
Neurology — Payments: $215,697
Chitra Venkatasubramanian, Md, MD
Neurology — Payments: $206,735
Babak Razavi, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $121,290